Exploratory Alzheimer's Disease Research Centers (P20 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

This funding opportunity announcement invites applications to plan and initiate collaborative activities that will develop and implement infrastructure appropriate for an Alzheimer's Disease Research Center (P30). 

Only one application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed.


  • Duke Internal: August 21, 2019
  • Letter of Intent Due Date(s): September 9, 2019
  • Application Due Date(s): October 9, 2019

RFA-AG-20-023 Expiration Date October 10, 2019

If the internal deadline has passed and you are interested in this opportunity, please email fundopps@duke.edu to find out if it is still open.

Agency Website

Eligibility Requirements

Current Alzheimer's Disease Research Center Program Directors/Principal Investigators under RFA-AG-19-001 or RFA-AG-20-004 are not eligible to apply for this FOA.  



Amount Description

Application budgets are limited to $750,000 in direct costs per year. Budget requests must reflect the actual needs of the proposed project.

The maximum project period is 3 years. 

    Funding Type





    Medical - Basic Science
    Medical - Clinical Science
    Medical - Translational

    Internal Nomination

    Owing to the sponsor's restriction on the number of applications that may be submitted from Duke, anyone wishing to pursue nomination should submit the following materials as one PDF.

    A letter of support from dean or chair - 1 to 1.5 pages
    Project Summary/Abstract – 30 lines of text
    Project Narrative – three sentences
    Specific Aims – 1 page
    * NIH Biosketch of project leader

    Please submit internal materials through My Research Proposal. (Code ILN)  https://www.grantinterface.com/Common/LogOn.aspx?eqs=ApVvmgXCk2Uj7AzWyDE...

    Instructions for creating an account (if needed) and submitting your materials: https://www.ctsi.duke.edu/myresearchproposal

    Internal Deadline

    August 21, 2019

    External Deadline

    October 9, 2019